Controversies of preoperative portal vein embolization

References

• Siegel R , MaJ, ZouZ, JemalA. Cancer statistics, 2014. CA Cancer J. Clin.64(1), 9–29 (2014).
   PubMed Web of Science ®Google Scholar
• Shoup M , GonenM, D'AngelicaMet al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J. Gastrointest. Surg.7(3), 325–330 (2003).
   PubMed Web of Science ®Google Scholar
• Ribero D , AbdallaEK, MadoffDC, DonadonM, LoyerEM, VautheyJN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br. J. Surg.94(11), 1386–1394 (2007).
   PubMed Web of Science ®Google Scholar
• Kishi Y , AbdallaEK, ChunYSet al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann. Surg.250(4), 540–548 (2009).
   PubMed Web of Science ®Google Scholar
• Jaeck D , OussoultzoglouE, RossoE, GregetM, WeberJC, BachellierP. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann. Surg.240(6), 1037–1049; discussion 1049–1051 (2004).
   PubMed Web of Science ®Google Scholar
• Abulkhir A , LimongelliP, HealeyAJet al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann. Surg.247(1), 49–57 (2008).
   PubMed Web of Science ®Google Scholar
• Di Stefano DR , de BaereT, DenysAet al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology234(2), 625–630 (2005).
   PubMed Web of Science ®Google Scholar
• Mise Y , SakamotoY, IshizawaTet al. A worldwide survey of the current daily practice in liver surgery. Liver Cancer2(1), 55–66 (2013).
   PubMed Web of Science ®Google Scholar
• Fausto N , CampbellJS, RiehleKJ. Liver regeneration. Hepatology43(2 Suppl. 1), S45–S53 (2006).
   PubMed Web of Science ®Google Scholar
• Schweizer W , DudaP, TannerSet al. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J. Hepatol.23(1), 71–78 (1995).
   PubMed Web of Science ®Google Scholar
• May BJ , TalenfeldAD, MadoffDC. Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J. Vasc. Int. Radiol.24(2), 241–254 (2013).
   PubMed Web of Science ®Google Scholar
• Nagino M , NimuraY, KamiyaJet al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology21(2), 434–439 (1995).
   PubMed Web of Science ®Google Scholar
• Taub R . Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol.5(10), 836–847 (2004).
   PubMed Web of Science ®Google Scholar
• Yamanaka N , OkamotoE, KawamuraEet al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology18(1), 79–85 (1993).
   PubMed Web of Science ®Google Scholar
• Dixon E , AbdallaE, SchwarzRE, VautheyJN. AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma. HPB (Oxford)12(5), 287–288 (2010).
   PubMed Web of Science ®Google Scholar
• de Meijer VE , KalishBT, PuderM, IjzermansJN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br. J. Surg.97(9), 1331–1339 (2010).
   PubMed Web of Science ®Google Scholar
• Vauthey JN , PawlikTM, RiberoDet al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol.24(13), 2065–2072 (2006).
   PubMed Web of Science ®Google Scholar
• Farges O , BelghitiJ, KianmaneshRet al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg.237(2), 208–217 (2003).
   PubMed Web of Science ®Google Scholar
• Vauthey JN , AbdallaEK, DohertyDAet al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl.8(3), 233–240 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson TN , TuckerGT, TannerMS, Rostami-HodjeganA. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl.11(12), 1481–1493 (2005).
   PubMed Web of Science ®Google Scholar
• Shah A , GoffetteP, HubertCet al. Comparison of different methods to quantify future liver remnants after preoperative portal vein embolization to predict postoperative liver failure. Hepatogastroenterology58(105), 109–114 (2011).
   PubMedGoogle Scholar
• Madoff DC , AbdallaEK, GuptaSet al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J. Vasc. Interv. Radiol.16(2 Pt 1), 215–225 (2005).
   PubMed Web of Science ®Google Scholar
• Shimamura T , NakajimaY, UneYet al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery121(2), 135–141 (1997).
   PubMed Web of Science ®Google Scholar
• Denys A , LacombeC, SchneiderFet al. Portal vein embolization with n-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J. Vasc. Interv. Radiol.16(12), 1667–1674 (2005).
   PubMed Web of Science ®Google Scholar
• Bent CL , LowD, MatsonMB, RenfrewI, FotheringhamT. Portal vein embolization using a nitinol plug (amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. Cardiovasc. Intervent. Radiol.32(3), 471–477 (2009).
   PubMed Web of Science ®Google Scholar
• de Baere T , DenysA, ParadisV. Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur. Radiol.19(6), 1435–1442 (2009).
   PubMed Web of Science ®Google Scholar
• Tsoumakidou G , TheocharisS, PtohisNet al. Liver hypertrophy after percutaneous portal vein embolization: comparison of n-butyl-2-cyanocrylate versus sodium acrylate-vinyl alcohol copolymer particles in a swine model. Cardiovasc. Intervent. Radiol.34(5), 1042–1049 (2011).
   PubMed Web of Science ®Google Scholar
• Guiu B , BizeP, GunthernD, DemartinesN, HalkicN, DenysA. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared with microparticles plus coils. Cardiovasc. Intervent. Radiol.36(5), 1306–1312 (2013).
   PubMed Web of Science ®Google Scholar
• Mise Y , AloiaTA, ConradC, HuangSY, WallaceMJ, VautheyJN. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J. Gastrointest. Surg.19(1), 133–141; discussion 141 (2015).
   PubMed Web of Science ®Google Scholar
• Denys A , PriorJ, BizePet al. Portal vein embolization: what do we know? Cardiovasc. Intervent. Radiol. 35(5), 999–1008 (2012).
   PubMed Web of Science ®Google Scholar
• Capussotti L , MuratoreA, FerreroA, AnselmettiGC, CorgnierA, ReggeD. Extension of right portal vein embolization to segment IV portal branches. Arch. Surg.140(11), 1100–1103 (2005).
   PubMedGoogle Scholar
• Kishi Y , MadoffDC, AbdallaEKet al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 144(5), 744–751 (2008).
   PubMed Web of Science ®Google Scholar
• de Baere T , TeriitehauC, DeschampsFet al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann. Surg. Oncol.17(8), 2081–2089 (2010).
   PubMed Web of Science ®Google Scholar
• Shindoh J , VautheyJN, ZimmittiGet al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J. Am. Coll. Surg.217(1), 126–133; discussion 133–124 (2013).
   PubMed Web of Science ®Google Scholar
• Kodama Y , ShawCM, MadoffDC. Complications of portal vein embolization. In: Venous Embolization of the Liver: Radiologic and Surgical Practice. MadoffDC, MakuuchiM, NaginoM, VautheyJN ( Eds). Springer-Verlag, London, UK, 159–168 (2011).
   Google Scholar
• Beal IK , AnthonyS, PapadopoulouAet al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br. J. Radiol.79(942), 473–478 (2006).
   PubMed Web of Science ®Google Scholar
• Zorzi D , ChunYS, MadoffDC, AbdallaEK, VautheyJN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann. Surg. Oncol.15(10), 2765–2772 (2008).
   PubMed Web of Science ®Google Scholar
• Covey AM , BrownKT, JarnaginWRet al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann. Surg.247(3), 451–455 (2008).
   PubMed Web of Science ®Google Scholar
• Muratore A , ZimmittiG, RiberoD, MellanoA, ViganòL, CapussottiL. Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it?Ann. Surg. Oncol.19(4), 1310–1315 (2012).
   PubMed Web of Science ®Google Scholar
• Fischer C , MelstromLG, ArnaoutakisDet al. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg.148(12), 1103–1108 (2013).
   PubMed Web of Science ®Google Scholar
• Jakobs TF , SaleemS, AtassiBet al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig. Dis. Sci.53(9), 2556–2563 (2008).
   PubMed Web of Science ®Google Scholar
• Gulec SA , PenningtonK, HallM, FongY. Preoperative y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J. Surg. Oncol.7, 6 (2009).
   PubMed Web of Science ®Google Scholar
• Vouche M , LewandowskiRJ, AtassiRet al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J. Hepatol.59(5), 1029–1036 (2013).
   PubMed Web of Science ®Google Scholar
• Garlipp B , de BaereT, DammRet al. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology59(5), 1864–1873 (2014).
   PubMed Web of Science ®Google Scholar
• Capussotti L , MuratoreA, BaracchiFet al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch. Surg.143(10), 978–982; discussion 982 (2008).
   PubMedGoogle Scholar
• Robles R , MarinC, Lopez-ConesaA, CapelA, Perez-FloresD, ParrillaP. Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. 38(7), 586–593 (2012).
   Google Scholar
• Pandanaboyana S , BellR, HidalgoEet al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery157(4), 690–698 (2015).
   PubMed Web of Science ®Google Scholar
• Schnitzbauer AA , LangSA, GoessmannHet al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann. Surg.255(3), 405–414 (2012).
   PubMed Web of Science ®Google Scholar
• Schadde E , ArdilesV, SlankamenacKet al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J. Surg.38(6), 1510–1519 (2014).
   PubMed Web of Science ®Google Scholar
• Hernandez-Alejandro R , BertensKA, Pineda-SolisK, CroomeKP. Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?Surgery157(2), 194–201 (2015).
   PubMed Web of Science ®Google Scholar
• Aloia TA , VautheyJN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?Ann. Surg.256(3), e9; author reply e16–e19 (2012).
   PubMed Web of Science ®Google Scholar
• Oldhafer KJ , DonatiM, JennerRM, StangA, StavrouGA. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J. Surg.38(6), 1504–1509 (2014).
   PubMed Web of Science ®Google Scholar